left ventricular remodeling

Advertisement
DocWire News EditorsHFSA 19 | April 6, 2023
The inhibition of SGLT-2 was not associated with an improvement in left ventricular (LV) reverse remodeling in patients ...
Read More
DocWire News EditorsAHA Scientific Sessions 2018 | April 11, 2023
Empagliflozin, an SGLT2 inhibitor, significantly reversed left ventricular (LV) remodeling in a population of diabetic ...
Advertisement
Advertisement
Latest News

April 25, 2025